Virpax Pharmaceuticals, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On September 16, 2024, Vanila M. Singh, MD, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Company of her intention to resign from the Board, effective immediately.
Extracted from this filing and checked against the source text.
Vanila M. Singh resigned as member of the Board of Directors at Virpax Pharmaceuticals, Inc..
On September 16, 2024, Vanila M. Singh, MD, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Company of her intention to resign from the Board, effective immediately.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.